172 related articles for article (PubMed ID: 32620091)
1. Incidence, prevalence, mortality, and causes of death in Waldenström macroglobulinemia: a nationwide, population-based cohort study.
Jeong S; Kong SG; Kim DJ; Lee S; Lee HS
BMC Cancer; 2020 Jul; 20(1):623. PubMed ID: 32620091
[TBL] [Abstract][Full Text] [Related]
2. Incidence, prevalence, mortality and causes of death in Takayasu Arteritis in Korea - A nationwide, population-based study.
Park SJ; Kim HJ; Park H; Hann HJ; Kim KH; Han S; Kim Y; Ahn HS
Int J Cardiol; 2017 May; 235():100-104. PubMed ID: 28283361
[TBL] [Abstract][Full Text] [Related]
3. Overall survival and competing risks of death in patients with Waldenström macroglobulinaemia: an analysis of the Surveillance, Epidemiology and End Results database.
Castillo JJ; Olszewski AJ; Kanan S; Meid K; Hunter ZR; Treon SP
Br J Haematol; 2015 Apr; 169(1):81-9. PubMed ID: 25521528
[TBL] [Abstract][Full Text] [Related]
4. Fifty-Year Incidence of Waldenström Macroglobulinemia in Olmsted County, Minnesota, From 1961 Through 2010: A Population-Based Study With Complete Case Capture and Hematopathologic Review.
Kyle RA; Larson DR; McPhail ED; Therneau TM; Dispenzieri A; Kumar S; Kapoor P; Cerhan JR; Rajkumar SV
Mayo Clin Proc; 2018 Jun; 93(6):739-746. PubMed ID: 29656787
[TBL] [Abstract][Full Text] [Related]
5. Incidence, mortality, and causes of death in physician-diagnosed primary Sjögren's syndrome in Korea: A nationwide, population-based study.
Kim HJ; Kim KH; Hann HJ; Han S; Kim Y; Lee SH; Kim DS; Ahn HS
Semin Arthritis Rheum; 2017 Oct; 47(2):222-227. PubMed ID: 28729155
[TBL] [Abstract][Full Text] [Related]
6. Incidence of secondary malignancies among patients with Waldenström macroglobulinemia: An analysis of the SEER database.
Castillo JJ; Olszewski AJ; Hunter ZR; Kanan S; Meid K; Treon SP
Cancer; 2015 Jul; 121(13):2230-6. PubMed ID: 25757851
[TBL] [Abstract][Full Text] [Related]
7. Temporal and geographic variations of Waldenstrom macroglobulinemia incidence: a large population-based study.
Wang H; Chen Y; Li F; Delasalle K; Wang J; Alexanian R; Kwak L; Rustveld L; Du XL; Wang M
Cancer; 2012 Aug; 118(15):3793-800. PubMed ID: 22139816
[TBL] [Abstract][Full Text] [Related]
8. Retrospective analysis of prognostic factors for Waldenstrӧm macroglobulinemia: a multicenter cooperative study in Japan.
Saito A; Isoda A; Kojima M; Yokohama A; Tsukune Y; Sasaki M; Ito S; Ohtsu A; Koike M; Murayama K; Moriya K; Tamura H; Matsumoto M; Nakahashi H; Tanosaki S; Sakura T; Kawamura T; Miyanaga T; Nakamura N; Murakami H; Handa H; Tsukamoto N
Int J Hematol; 2017 Nov; 106(5):681-690. PubMed ID: 28687991
[TBL] [Abstract][Full Text] [Related]
9. Elevated risk of venous but not arterial thrombosis in Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.
Hultcrantz M; Pfeiffer RM; Björkholm M; Goldin LR; Turesson I; Schulman S; Landgren O; Kristinsson SY
J Thromb Haemost; 2014 Nov; 12(11):1816-21. PubMed ID: 25196979
[TBL] [Abstract][Full Text] [Related]
10. Incidence of lymphoplasmacytic lymphoma/Waldenström's macroglobulinaemia in Japan and Taiwan population-based cancer registries, 1996-2003.
Iwanaga M; Chiang CJ; Soda M; Lai MS; Yang YW; Miyazaki Y; Matsuo K; Matsuda T; Sobue T
Int J Cancer; 2014 Jan; 134(1):174-80. PubMed ID: 23784625
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, Age at Diagnosis, Mortality, and Cause of Death in Retinitis Pigmentosa in Korea-A Nationwide Population-based Study.
Na KH; Kim HJ; Kim KH; Han S; Kim P; Hann HJ; Ahn HS
Am J Ophthalmol; 2017 Apr; 176():157-165. PubMed ID: 28130043
[TBL] [Abstract][Full Text] [Related]
12. Clinical factors associated with response or survival after chemotherapy in patients with Waldenström macroglobulinemia in Korea.
Lee HS; Kim K; Yoon DH; Kim JS; Bang SM; Lee JO; Eom HS; Lee H; Kim I; Lee WS; Bae SH; Kim SH; Lee MH; Do YR; Lee JH; Hong J; Shin HJ; Lee JH; Mun YC; Min CK
Biomed Res Int; 2014; 2014():253243. PubMed ID: 24995279
[TBL] [Abstract][Full Text] [Related]
13. Familial Waldenstrom's macroglobulinemia and relation to immune defects, autoimmune diseases, and haematological malignancies--A population-based study from northern Sweden.
Brandefors L; Kimby E; Lundqvist K; Melin B; Lindh J
Acta Oncol; 2016; 55(1):91-8. PubMed ID: 26559865
[TBL] [Abstract][Full Text] [Related]
14. Waldenström's macroglobulinemia: incidence patterns in the United States, 1988-1994.
Groves FD; Travis LB; Devesa SS; Ries LA; Fraumeni JF
Cancer; 1998 Mar; 82(6):1078-81. PubMed ID: 9506352
[TBL] [Abstract][Full Text] [Related]
15. Increasing Incidence of B-Cell Non-Hodgkin Lymphoma and Occurrence of Second Primary Malignancies in South Korea: 10-Year Follow-up Using the Korean National Health Information Database.
Kim JS; Liu Y; Ha KH; Qiu H; Rothwell LA; Kim HC
Cancer Res Treat; 2020 Oct; 52(4):1262-1272. PubMed ID: 32599988
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors and primary treatment for Waldenström macroglobulinemia - a Swedish Lymphoma Registry study.
Brandefors L; Melin B; Lindh J; Lundqvist K; Kimby E
Br J Haematol; 2018 Nov; 183(4):564-577. PubMed ID: 30198549
[TBL] [Abstract][Full Text] [Related]
17. Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden.
Kristinsson SY; Björkholm M; Goldin LR; McMaster ML; Turesson I; Landgren O
Blood; 2008 Oct; 112(8):3052-6. PubMed ID: 18703425
[TBL] [Abstract][Full Text] [Related]
18. Differential characteristics of Waldenström macroglobulinemia according to patterns of familial aggregation.
Royer RH; Koshiol J; Giambarresi TR; Vasquez LG; Pfeiffer RM; McMaster ML
Blood; 2010 Jun; 115(22):4464-71. PubMed ID: 20308603
[TBL] [Abstract][Full Text] [Related]
19. Cause-specific mortality in individuals with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia, 2000-2016.
Dalal NH; Dores GM; Curtis RE; Linet MS; Morton LM
Br J Haematol; 2020 Jun; 189(6):1107-1118. PubMed ID: 32090327
[TBL] [Abstract][Full Text] [Related]
20. Associated malignancies in patients with Waldenström's macroglobulinemia and their kin.
Hanzis C; Ojha RP; Hunter Z; Manning R; Lewicki M; Brodsky P; Ioakimidis L; Tripsas C; Patterson CJ; Sheehy P; Treon SP
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):88-92. PubMed ID: 21454200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
